INTRAVENOUS FERRIC CARBOXYMALTOSE VS ORAL IRON IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY: RESULTS OF THE RANDOMISED FIND-CKD STUDY

被引：0
|
作者：
Macdougall, I. D. [1 ]
Bock, A. [2 ]
Carrera, F. [3 ]
Eckardt, K-U [4 ]
Gaillard, C. [5 ]
Van Wyck, D. [6 ]
Roubert, B. [7 ]
Nolen, J. [7 ]
Roger, S. D. [8 ]
机构：
[1] Kings Coll Hosp London, London, England
[2] Kantonsspital, Aarau, Switzerland
[3] Eurodial, Leiria, Portugal
[4] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany
[5] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
[6] Davita Healthcare Partners Inc, Denver, CO USA
[7] Vifor Pharma, Glattbrugg, Switzerland
[8] Renal Res, Gosford, Australia
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SO049
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
    Macdougall, Iain C.
    Bock, Andreas H.
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo
    Van Wyck, David
    Roubert, Bernard
    Nolen, Jacqueline G.
    Roger, Simon D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (11) : 2075 - 2084
  • [2] Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
    Macdougall, Iain C.
    Bock, Andreas H.
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo
    Van Wyck, David
    Meier, Yvonne
    Larroque, Sylvain
    Roger, Simon D.
    [J]. BMC NEPHROLOGY, 2017, 18
  • [3] Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial
    Iain C. Macdougall
    Andreas H. Bock
    Fernando Carrera
    Kai-Uwe Eckardt
    Carlo Gaillard
    David Van Wyck
    Yvonne Meier
    Sylvain Larroque
    Simon D. Roger
    [J]. BMC Nephrology, 18
  • [4] The FIND-CKD study-a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
    Macdougall, Iain C.
    Bock, Andreas
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo
    Van Wyck, David
    Roubert, Bernard
    Cushway, Timothy
    Roger, Simon D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) : 843 - 850
  • [5] IV FERRIC CARBOXYMALTOSE (FCM) IS A CONVENIENT AND WELL-TOLERATED FIRST-LINE THERAPY FOR THE TREATMENT OF ANAEMIA IN PATIENTS WITH IRON DEFICIENCY AND NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (ND-CKD): RESULTS OF THE RANDOMISED FIND-CKD STUDY
    Roger, S. D.
    Bock, A.
    Carrera, F.
    Eckardt, K-U
    Gaillard, C.
    Van Wyck, D.
    Roubert, B.
    Nolen, J.
    Macdougall, C.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 21 - 21
  • [6] EFFICACY OF ORAL IRON FOR TREATING IRON DEFICIENCY IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD)
    Macdougall, I. C.
    Bock, A. H.
    Carrera, F.
    Eckardt, K-U
    Gaillard, C.
    Van Wyck, D.
    Meier, Y.
    Larroque, S.
    Perrin, A.
    Roger, S. D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [7] THE SAFETY OF INTRAVENOUS (IV) FERRIC CARBOXYMALTOSE (FCM) IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD (ND-CKD): 1-YEAR RESULTS FROM THE FIND-CKD TRIAL
    Roger, Simon
    Bock, Andreas H.
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo A.
    Van Wyck, David B.
    Meier, Yvonne
    Larroque, Sylvain
    Macdougall, Iain C.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 15 - 16
  • [8] Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
    Gaillard, Carlo A.
    Bock, Andreas H.
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Van Wyck, David B.
    Bansal, Sukhvinder S.
    Cronin, Maureen
    Meier, Yvonne
    Larroque, Sylvain
    Roger, Simon D.
    Macdougall, Iain C.
    [J]. PLOS ONE, 2016, 11 (06):
  • [9] A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
    Qunibi, Wajeh Y.
    Martinez, Carlos
    Smith, Mark
    Benjamin, Joseph
    Mangione, Antoinette
    Roger, Simon D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (05) : 1599 - 1607
  • [10] Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
    Roger, Simon D.
    Gaillard, Carlo A.
    Bock, Andreas H.
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Van Wyck, David B.
    Cronin, Maureen
    Meier, Yvonne
    Larroque, Sylvain
    Macdougall, Iain C.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (09) : 1530 - 1539
12345